Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study based on scientific principles, reproducible test method

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Unnamed
Year:
1963
Reference Type:
review article or handbook
Title:
Selected non-heterocyclic polycyclic aromatic hydrocarbons - IPCS Environmental Health Criteria 202 (§)
Author:
WHO
Year:
1998
Bibliographic source:
International Programme on Chemical Safety (IPCS), WHO - World Health Organization, Geneva, Switzerland
Reference Type:
review article or handbook
Title:
Toxicological Profile for Polycyclic Aromatic Hydrocarbons
Author:
ATSDR
Year:
1995
Bibliographic source:
US Department of Health & Human Services, Agency for Toxic Substances and Disease Registry, August 1995, 1-487

Materials and methods

Principles of method if other than guideline:
Delayed hypersensitivity/contact sensitisation: Intradermal injection of the agents into the foot pad for induction in the presence of Freund´s adjuvant, followed by topical/epidermal challenge
(method according to: Gell PG and Benacerraf B J. Exp. Med. 113, 571 (1961)
GLP compliance:
no
Type of study:
intracutaneous test
Justification for non-LLNA method:
LLNA test method not available at time of the study

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzo[def]chrysene
EC Number:
200-028-5
EC Name:
Benzo[def]chrysene
Cas Number:
50-32-8
Molecular formula:
C20H12
IUPAC Name:
benzo[pqr]tetraphene
Test material form:
solid
Details on test material:
- Substance type: organic
Phys.-chem. properties (data from EU 2008: Coal-Tar Pitch, high temperature - Risk Assessment. European Union Risk Assessment Report, The Netherlands, and WHO 1998: EHC 202)
- Vapour pressure: 7.3E-7 Pa (at 25 °C)
- Water solubility: in freshwater, approx. 1.5 - 3.8 µg/L (20 - 25 °C);
- Henry's law constant: 0.034 Pa*m³/mol (at 20 °C)
- log Pow: = 6.13 - 6.5
- pKa: not applicable
- Stability in water: limited due to photolytic decomposition and evaporation
- Stability in light: instable in the presence of UV
- pH dependance on stability: not applicable
Specific details on test material used for the study:
- Name of test material (as cited in study report): 3,4-benzpyrene (BP)
- Analytical purity: "highly purified" (acc. to report)

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
female

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal
Vehicle:
other: emulsion in complete Freund´s adjuvant with saline
Concentration / amount:
125 µg into each front foot pad, total 250 µg
Day(s)/duration:
exposure period 2 - 3 wks
Adequacy of induction:
not specified
Challengeopen allclose all
No.:
#1
Route:
epicutaneous, open
Vehicle:
other: acetone-olive oil mixture (not further specified)
Concentration / amount:
0.001 %
Day(s)/duration:
24 h
Adequacy of challenge:
not specified
No.:
#2
Route:
epicutaneous, open
Vehicle:
other: acetone-olive oil mixture (not further specified)
Concentration / amount:
0.01 %
Day(s)/duration:
24 h
Adequacy of challenge:
not specified
No.:
#3
Route:
epicutaneous, open
Vehicle:
other: acetone-olive oil mixture (not further specified)
Concentration / amount:
0.1 %
Day(s)/duration:
24 h
Adequacy of challenge:
not specified
No.:
#4
Route:
epicutaneous, open
Vehicle:
other: acetone-olive oil mixture (not further specified)
Concentration / amount:
1 %
Day(s)/duration:
24 h
Adequacy of challenge:
not specified
No. of animals per dose:
6, 16, and 10 were used for 3-methylcholanthrene (MC), BaP and 9,10-dimethyl-1,2-benzanthracene (DMBA), respectively
Details on study design:
RANGE FINDING TESTS: no data

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1 i.d.
- Exposure period: 2 - 3 weeks
- Test groups: 4
- Control group: 1
- Site: each foot pad
- Frequency of applications: 1x
- Concentrations: 250 µg (125 µg/0.1 mL into each front foot pad)
- Auxiliary agent: emulsion in complete Freund´s adjuvant with saline

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 2 - 3 weeks after induction
- Exposure period: 24 h
- Test groups: 4
- Control group: 1
- Site: ventral or dorsal shaved skin
- Concentrations: 0.001, 0.01, 0.1,and 1 % (one drop each applied)
- Evaluation (hr after challenge): 24

OTHER:
- Scoring system
according to Gell PG and Benacerraf B J. Exp. Med. 113, 571 (1961): from +++ to 0

Challenge controls:
PAH known to be contact sensitisers in this test system: MC and DMBA
Positive control substance(s):
yes
Remarks:
3- methylcolanthrene (MC) and 9,1-dimethyl-1,2-benzanthracene (DMBA)

Results and discussion

Positive control results:
MC +++ (>= 0.1 %); DMBA +++ (1 %).
Dose-related intensity of the responses

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.001%
No. with + reactions:
16
Total no. in group:
16
Clinical observations:
contact reactivity with score +
Remarks on result:
positive indication of skin sensitisation
Remarks:
score + indicates the onset of a sensitising effect
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.01%
No. with + reactions:
16
Total no. in group:
16
Clinical observations:
contact reactivity with score ++
Remarks on result:
positive indication of skin sensitisation
Remarks:
score ++ shows a moderate sensitising response
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.1%
No. with + reactions:
16
Total no. in group:
16
Clinical observations:
contact reactivity with score +++
Remarks on result:
positive indication of skin sensitisation
Remarks:
score +++ demonstrates a clear sensitising response
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
1 %
No. with + reactions:
16
Total no. in group:
16
Clinical observations:
contact reactivity with score +++
Remarks on result:
positive indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
solvent without test substance
No. with + reactions:
0
Total no. in group:
4
Clinical observations:
reponse - to +- (negative to slight erythema)
Remarks on result:
no indication of skin sensitisation
Remarks:
negative response on challenge
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
0.1 %
No. with + reactions:
6
Total no. in group:
6
Clinical observations:
Score ++
Remarks on result:
positive indication of skin sensitisation
Remarks:
score ++ shows a moderate sensitising response

Any other information on results incl. tables

There was a dose-related increase in the intensity of the delayed contact reactivity. There was also cross-reactivity with MC and DMBA as challenging agent and BaP with previous inducer. The intensity of the response was dose-related but primarily expressed at the higher challenge doses, i.e. weaker than with BaP as challenger.

Applicant's summary and conclusion

Interpretation of results:
Category 1 (skin sensitising) based on GHS criteria
Remarks:
dose related intensity of the response with regard to the test substance concentration during challenge